Min‐Shu Hsieh

SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization

Marina K. Baine, Min‐Shu Hsieh, W. Victoria Lai et al. · Journal of Thoracic Oncology · 2020 · 468 citations · Full text

Immunogenetics, Sclc Subtypes, Histopathologic Characterization +10

Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study

Chia‐Chi Lin, Jin‐Yuan Shih, Chong‐Jen Yu et al. · The Lancet Respiratory Medicine · 2017 · 143 citations

Oncology, Non-small-cell Lung Cancer, Somatic Variant +11

Computed tomography-guided patent blue vital dye localization of pulmonary nodules in uniportal thoracoscopy

Mong‐Wei Lin, Yao‐Hui Tseng, Yee-Fan Lee et al. · Journal of Thoracic and Cardiovascular Surgery · 2016 · 128 citations · Full text

Medical Imaging, Pneumothorax, Multiple Pulmonary Nodule +7

SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma

Min‐Shu Hsieh, Yi‐Hsuan Lee, Yih‐Leong Chang · Human Pathology · 2016 · 118 citations

Mucoepidermoid Carcinoma, Pathology, Cancer Diagnosis +6

Clinical and the Prognostic Characteristics of Lung Adenocarcinoma Patients with ROS1 Fusion in Comparison with Other Driver Mutations in East Asian Populations

Yen‐Fu Chen, Min‐Shu Hsieh, Shang‐Gin Wu et al. · Journal of Thoracic Oncology · 2014 · 81 citations

Ros1 Fusion, Oncology, East Asian Populations +10